Shares of Moderna Inc. (NAS:MRNA) shed 4.36% to $352.43 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index (NASDAQ:COMP) falling 1.55% to 15,537.69 and Dow Jones Industrial Average (DOW:DJIA) falling 1.86% to 34,483.72. The stock's fall snapped a two-day winning streak. Moderna Inc. closed $145.06 below its 52-week high ($497.49), which the company achieved on August 10th.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. (NYS:ABBV) fell 1.38% to $115.28, Amgen Inc. (NAS:AMGN) fell 2.26% to $198.88, and AstraZeneca PLC ADR (NAS:AZN) fell 1.26% to $54.83. Trading volume (24.7 M) eclipsed its 50-day average volume of 12.6 M.